Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
2 results loaded, newest first. End of these results.
Mirum Pharmaceuticals appointed Dr. Rob Myers as CMO as it prepares pivotal clinical readouts and regulatory filings next year for HDV, FOP and cholestatic pruritus, while expanding its rare-disease pipeline and applying AI to R&D.
Mirum Pharmaceuticals (MIRM) appointed Rob Myers, M.D., as Chief Medical Officer, effective September 21, 2026. He will join the leadership team and lead the company’s global medical and clinical development function.